Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways
- PMID: 27401285
- DOI: 10.1016/j.jep.2016.07.015
Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways
Abstract
Ethnopharmacological relevance: Panax quinquefolium saponin (PQS) is the active component extracted from traditional Chinese medicine Panax quinquefolius L. and has been widely used as a supplement to dual antiplatelet drugs (DA) for treatment of coronary artery disease (CAD) for two decades; however, the efficacy of PQS combined with DA against platelet adhesion to endothelial cells (ECs), an essential step in thrombosis, remains unclear.
Aim of the study: To compare PQS combined with DA and DA alone in inhibiting platelet adhesion to injured human umbilical vein endothelial cells (HUVECs) and to explore the possible mechanisms focusing on PI3K/AKT, COX-2/6-keto-PGF1α, and COX-1/TXB2 pathways.
Methods: HUVECs injured by oxidized low-density lipoprotein (ox-LDL) were randomly allocated into control, model, DA, PQS+DA (P+DA), LY294002 (a PI3K inhibitor)+DA (L+DA), and LY294002+PQS+DA (LP+DA) groups. HUVEC apoptosis, platelet adhesion to injured HUVECs, and platelet CD62p expression were assayed by fluorescence activated cell sorting (FACS). The concentrations of 6-keto-PGF1α and TXB2 in the supernatant were measured by radioimmunoassay. Protein expression of phosphorylated-PI3K, PI3K, phosphorylated-AKT, AKT, COX-1, and COX-2 in both platelets and HUVECs was evaluated by western blot.
Results: Compared to DA alone, PQS combined with DA reduced platelet adhesion to HUVECs and HUVEC apoptosis more potently, increased the concentration of supernatant 6-keto-PGF1α and up-regulated phospho-AKT protein in HUVECs. LY294002 mitigated the effects of PQS on HUVEC apoptosis and platelet adhesion.
Conclusions: These findings show that PQS as a powerful supplement to DA, attenuated HUVEC apoptosis and improved the DA-mediated reduction of platelet adhesion to injured HUVECs and the underlying mechanisms may be associated with PI3K/AKT and COX pathways in HUVECs and platelets. PQS might provide a new complementary approach to improve the prognosis of thrombotic diseases in future.
Keywords: Cyclooxygenase; Dual antiplatelet; Endothelial cell; Panax quinquefolium saponin; Platelet adhesion; Thrombogenesis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro.Thromb Res. 2016 May;141:146-52. doi: 10.1016/j.thromres.2016.03.022. Epub 2016 Mar 23. Thromb Res. 2016. PMID: 27043068
-
[Chinese Herbal Compounds for Supplementing Qi and Activating Blood Circulation Combined with Dual Antiplatelet Drugs Alleviated Human Umbilical Vein Endothelial Cell Injury and Platelet Adhe- sion via Up-regulation of P13K/Akt Pathway].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016 Jul;36(7):842-848. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016. PMID: 30634213 Chinese.
-
Panax quinquefolius saponins combined with dual antiplatelet drug therapy alleviate gastric mucosal injury and thrombogenesis through the COX/PG pathway in a rat model of acute myocardial infarction.PLoS One. 2018 Mar 27;13(3):e0194082. doi: 10.1371/journal.pone.0194082. eCollection 2018. PLoS One. 2018. PMID: 29584740 Free PMC article.
-
Current issues in thrombosis prevention with antiplatelet drugs.Drugs. 1986 Jun;31(6):517-49. doi: 10.2165/00003495-198631060-00004. Drugs. 1986. PMID: 3525085 Review.
-
[Variable platelet response to aspirin and new therapeutic targets].J Mal Vasc. 2009 Feb;34(1):16-25. doi: 10.1016/j.jmv.2008.10.009. Epub 2008 Dec 24. J Mal Vasc. 2009. PMID: 19110389 Review. French.
Cited by
-
Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety.Evid Based Complement Alternat Med. 2021 Oct 27;2021:9956248. doi: 10.1155/2021/9956248. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34745309 Free PMC article. Review.
-
Application Progress and Prospect of Herbal and Western Medicine Combined with Antiplatelet Therapy for Cardiovascular Events.Evid Based Complement Alternat Med. 2021 Jul 29;2021:5563987. doi: 10.1155/2021/5563987. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34367302 Free PMC article. Review.
-
Panax quinquefolius saponins combined with dual antiplatelet therapy enhanced platelet inhibition with alleviated gastric injury via regulating eicosanoids metabolism.BMC Complement Med Ther. 2023 Aug 18;23(1):289. doi: 10.1186/s12906-023-04112-7. BMC Complement Med Ther. 2023. PMID: 37596586 Free PMC article.
-
Biological Amnion Prevents Flexor Tendon Adhesion in Zone II: A Controlled, Multicentre Clinical Trial.Biomed Res Int. 2019 Apr 3;2019:2354325. doi: 10.1155/2019/2354325. eCollection 2019. Biomed Res Int. 2019. PMID: 31073521 Free PMC article. Clinical Trial.
-
A review of natural compounds to regulate platelet aggregation: molecular mechanism and research advance.Front Pharmacol. 2025 Jun 27;16:1537776. doi: 10.3389/fphar.2025.1537776. eCollection 2025. Front Pharmacol. 2025. PMID: 40657646 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous